A Highly Heterogeneous HIV-1 Epidemic in the Central African Republic
Marcel Massanga*, Justin Ndoyo*, Dale J. Hu†, Chou-Pong Pau†, Stephanie Lee-Thomas†, Reginald Hawkins†, Dominique Senekian*, Mark A. Rayfield†, J. Richard George†, Amédée Zengais*, Noel Ngalla Yatere*, Victor Yossangang*, Aliou Samori*, Gerald Schochetman†, and Timothy J. Dondero†
Author affiliations: *Ministère de la Santé Publique et de la Population, Central African Republic; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Figure 2. Serotype distribution among 173 HIV-1-infected persons. Letters indicate serologic reactivities to peptides to the given HIV-1 subtypes A-F. Sera reactive to two different subtype peptides are given as a combination of two letters. Multiple refers to sera that reacted to more than two different subtype peptides. Nonreactive refers to sera that did not react to any of the peptides used.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.